Exploring Emerging Trends and Future Prospects of Cancer Vaccines in Oncology Treatment Cancer vaccines represent a transformative approach in oncology, aiming to stimulate the immune system to recognize and eliminate cancer cells. Unlike traditional vaccines that prevent infectious diseases, cancer vaccines are designed to either prevent certain types of cancer or treat existing cancer by boosting the body's natural defenses. The dynamic landscape of cancer immunotherapy is expanding rapidly, with several innovative vaccines progressing through clinical trials, offering hope for improved survival rates and enhanced quality of life for patients worldwide. Understanding the Mechanism of Action Behind Cancer Vaccines and Immune Response Cancer Vaccines work by introducing specific antigens associated with tumors, training the immune system to detect and attack cancerous cells. These vaccines often target tumor-associated antigens (TAAs) or neoantigens, unique to cancer cells, which helps minimize damage to healthy tissue. Two primary categories exist: prophylactic vaccines aimed at preventing cancer by targeting viruses linked to cancer development, such as the human papillomavirus (HPV) vaccine preventing cervical cancer, and therapeutic vaccines designed to treat existing cancers by enhancing the immune response. Cancer Vaccines-https://www.coherentmarketinsights.com/market-insight/cancer-vaccines-market-1209